Does anyone know the reference of the pre-clinical evidence of the metabolic effects of chronic enteral treatment of omarigliptin in C57BL6 mice?

With pharmacokinetics and pharmacodynamics, doses, impact on body weight, food intake, fasting glycaemia, duration of the treatment, etc? I found evidence in rats and in dogs, nothing in mice....

09 October 2017 5,431 0 View